Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2014
11/20/2014US20140343021 Adjuvant to thrombolytic therapy for the treatment of frostbite
11/20/2014US20140343012 Compositions and methods for treating joints
11/20/2014US20140343005 Aqueous compositions comprising arbekacin
11/20/2014US20140342991 Composition for improving brain function and method for improving brain function
11/20/2014US20140342985 Polymeric Devices for Controlled Release of Active Agents
11/20/2014US20140342976 Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-beta superfamily members
11/20/2014US20140342018 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
11/20/2014US20140342016 Non-invasive refractive treatment using nanoparticles
11/20/2014US20140342010 Use of foti to enhance stem cell mobilization and proliferation
11/20/2014US20140342006 Methods for Preparing Injectable Protein Microparticle Suspensions
11/20/2014US20140342005 Methods for the production, modification and use of metallic nanonparticles
11/20/2014US20140342003 Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
11/20/2014US20140342002 Particulate materials
11/20/2014US20140342001 Medicaments
11/20/2014US20140341999 Antitubercular composition and method for producing same
11/20/2014US20140341998 Pharmaceutical composition for inhalation
11/20/2014US20140341997 Continuous process for preparing microspheres and microspheres prepared thereby
11/20/2014US20140341996 Nanoengineering of Functionalized Polymers and Its Manufacturing and Formulation Methods for Personalized Cancer Therapies
11/20/2014US20140341995 Conjugate With Target-Finding Ligand and Use Thereof
11/20/2014US20140341994 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
11/20/2014US20140341993 Solid pharmaceutical composition comprising an antibiotic from the quinolone family and method of production thereof
11/20/2014US20140341992 Compositions of imatinib
11/20/2014US20140341991 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/20/2014US20140341990 Controlled Release Formulations of Nisoldipine
11/20/2014US20140341989 Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
11/20/2014US20140341988 Orally dispersible drug formulations
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/20/2014US20140341985 Method of reducing somnolence in patients treated with tizanidine
11/20/2014US20140341984 Tamper resistant pharmaceutical formulations
11/20/2014US20140341982 Vaccination With Immuno-Isolated Cells Producing An Immunomodulator
11/20/2014US20140341981 Emulsion stabilization via silicilic acid complexation
11/20/2014US20140341980 Method to Enhance an Immune Response of Nucleic Acid Vaccination
11/20/2014US20140341979 Nanodrug targeting protein geranylgeranylation
11/20/2014US20140341975 Pathogen and substance traps
11/20/2014US20140341974 Liposomal Vaccine Adjuvants and Methods of Making and Using Same
11/20/2014US20140341973 Micron taiwanofungus camphoratus liposome structure
11/20/2014US20140341972 Method to induce neovascular formation and tissue regeneration
11/20/2014US20140341968 Intraocular Drug Delivery Systems
11/20/2014US20140341967 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications
11/20/2014US20140341966 Steroid-containing sustained release intraocular implants and related methods
11/20/2014US20140341955 Stable bubbles via particle absorption by electrostatic interaction
11/20/2014US20140341954 Stable emulsions via particle absorption by electrostatic interaction
11/20/2014US20140341940 Immunomodulator for the treatment of cancerous tumors in the epithelial tissue lining surfaces inside or outside body organs
11/20/2014US20140341925 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341924 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341866 Cell tissue gel containing collagen and hyaluronan
11/20/2014US20140341815 Delivery system for remote treatment of an animal
11/20/2014US20140341803 Stable nanoemulsions useful in the treatment of cancer
11/18/2014US8889894 Compounds for use in therapy
11/18/2014US8889838 Removal of serine proteases by treatment with finely divided silicon dioxide
11/18/2014US8889791 Thermoresponsive, biodegradable, elastomeric material
11/18/2014US8889745 Fibrous calcium pyrophosphate particles and methods of making and using same
11/18/2014US8889740 Composition and method for treating neurological disease
11/18/2014US8889735 Method for treating asthenopia
11/18/2014US8889728 Stable pharmaceutical compositions of carvedilol
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8889663 Formulation for oral transmucosal administration of lipid-lowering drugs
11/18/2014US8889659 Pain relief compositions, manufacture and uses
11/18/2014US8889655 Compositions and methods for preventing infectious diseases in females
11/18/2014US8889650 Antimelancholic medicine prepared with jujube camp materials
11/18/2014US8889618 C-terminal fragments of glucagon-like peptide-1 (GLP-1)
11/18/2014US8889617 Liquid food composition
11/18/2014US8889616 MUC1 based glycolipopeptide vaccine with adjuvant
11/18/2014US8889398 Composition for inactivating an enveloped virus
11/18/2014US8889396 Methods and compositions for improving growth of meat-type poultry
11/18/2014US8889346 Propofol formulations with non-reactive container closures
11/18/2014US8889237 Excipient system and medical container for erythrocyte enriched liquid
11/18/2014US8889213 Processes for coating a carrier with microparticles
11/18/2014US8889196 Dental composites comprising nanoparticles of amorphous calcium phosphate
11/18/2014US8889195 Compositions comprising calcium citrate malate and methods for making the same
11/18/2014US8889193 Sustained delivery of therapeutic agents to an eye compartment
11/18/2014US8889192 Magnetic nanomedicine for inhibiting/treating human prostate cancer
11/18/2014US8889191 Sustained-release formulations of topiramate
11/18/2014US8889190 Extended-release topiramate capsules
11/18/2014US8889189 Dissolution composition for examining drug solubility
11/18/2014US8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses
11/18/2014US8889187 Once a day amoxicillin product comprising immediate and delayed release dosage forms
11/18/2014US8889186 Modified release compositions comprising tacrolimus
11/18/2014US8889185 Modified release compositions comprising tacrolimus
11/18/2014US8889184 Particulate form of a pharmaceutical composition which is easy to swallow
11/18/2014US8889182 Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889180 Coated drug delivery formulations
11/18/2014US8889179 Membrane
11/18/2014US8889176 Method of managing or treating pain
11/18/2014US8889175 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
11/18/2014US8889174 Zero-order prolonged release coaxial implants
11/18/2014US8889173 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
11/18/2014US8889168 Stem cell capture and immobilization coatings for medical devices and implants
11/18/2014US8889161 Microencapsulated compositions and methods for tissue mineralization
11/18/2014US8889160 Ophthalmic compositions with biguanide and PEG-glycerol esters
11/18/2014US8889158 Intra-articularly supplementation method for treating joint diseases and injuries
11/18/2014US8889157 Composition for cardiovascular treatment
11/18/2014US8889156 Calcium-binding agents induce hair growth and/or nail growth
11/18/2014US8889155 Gel composition for treating mycosis
11/18/2014US8889154 Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
11/18/2014US8889123 Compositions and soft tissue replacement methods
11/18/2014US8889119 Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy
11/18/2014US8889115 Ion binding polymers and uses thereof
11/18/2014US8889113 Compositions and kits for the removal of irritating compounds from bodily surfaces
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 2991